secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2022-03-29T23:59:59+00:00
Accession:  0001171843-22-002162
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics FY2021 revenue up 17% to $24.9M; net loss narrows to $0.7M from $3.9M
--------------------------------------------------------------------------------

- Full-year revenue $24.9M (+17% YoY); net loss $0.7M ($0.12/diluted) vs $3.9M ($0.70) loss in 2020.
- Q4 revenue $6.4M (+21% YoY) but Q4 net loss widened to $1.6M ($0.29/diluted) from $0.5M ($0.10).
- PPP loan of $2.2M forgiven; $2.6M employee retention credits recognized; $3.3M in legal settlement charges.
- Resumed quarterly dividend in Q4 2021 after pandemic suspension; board to evaluate future dividends.
- Exploring strategic alternatives; year-end cash $2.0M, working capital $4.5M, equipment debt $1.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184322002162/0001171843-22-002162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184322002162/f8k_032922.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-002162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer